- Home
- CLDI vs KFFB Comparison
CLDI vs KFFB Comparison
Compare CLDI & KFFB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CLDI | KFFB |
|---|---|---|
| Founded | 2014 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4M | 45.0M |
| IPO Year | 2021 | 2004 |
Fundamental Metrics
Financial Performance| Metric | CLDI | KFFB |
|---|---|---|
| Price | $1.34 | $5.60 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 3.4K |
| Earning Date | 05-14-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 109.52 |
| EPS | N/A | ★ 0.15 |
| Revenue | ★ $45,000.00 | $15,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $37.20 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.09 | $3.01 |
| 52 Week High | $1.93 | $5.66 |
Technical Indicators
Market Signals| Indicator | CLDI | KFFB |
|---|---|---|
| Relative Strength Index (RSI) | 59.87 | 58.69 |
| Support Level | $1.29 | $4.23 |
| Resistance Level | $1.55 | $5.65 |
| Average True Range (ATR) | 0.15 | 0.08 |
| MACD | -0.06 | -0.02 |
| Stochastic Oscillator | 10.61 | 40.91 |
Price Performance
Historical ComparisonAbout CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a biotechnology company pioneering the development of targeted therapies with the potential to deliver genetic medicines to distal sites of disease. The company's proprietary RedTail platform features an engineered enveloped oncolytic virus designed for systemic delivery and targeting of metastatic sites. Its technology is intended to shield the virus from immune clearance, allowing virotherapy to effectively reach tumor sites, induce tumor lysis, and deliver potent genetic medicine(s) to metastatic locations. Its product candidates include The RedTail for Metastatic Solid Tumors, CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-101 (NeuroNova) for Newly Diagnosed High Grade Glioma.
About KFFB Kentucky First Federal Bancorp
Kentucky First Federal Bancorp is a holding company. The company, through its subsidiaries, is engaged mainly in the business of accepting deposits from the general public and using such funds to originate loans secured by first mortgages on owner-occupied, residential real estate and other loans secured by real estate. Its primary products and services include Residential mortgage loans, Multi-family loans, Construction loans, and types of deposits etc. The company mainly operates in Perry, Franklin, Boyle, and Garrard and surrounding counties in Kentucky, USA.